Consensus on the Use of Follow-On Disease-Modifying Treatments for MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations
Mult. Scler. 2022 Dec 01;28(14)2177-2189, WJ Brownlee, C Wolf, HP Hartung, T Dingermann, N Anshasi, RA Clark, M Trojano, K Selmaj, BM Uitdehaag, C Tur, J Wuerfel, G Dallmann, J Witte, M Sintzel, O Bobrovnikova, JA CohenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.